A surge in US Food and Drug Administration (FDA) rejections and delays has highlighted chemical, manufacturing and controls (CMC) as a major barrier to approval in cell and gene therapy development.

On today’s show, we begin with Frankie Ramos, Director of Campaigns and Organizing at CURYJ (Communities United for Restorative Youth Justice), joined by Mike Muscadine, Community Peace Manager. They ...

Jerne, N. K., Nordin, A. A., and Henry, C., in Cell-bound Antibodies, edit. by Amos, B., and Koprowski, H., 109 (Wistar Inst. Press, Philadelphia, 1963).